ABSTRAK
Introduction Handling the remained body affected by COVID-19 in Indonesia is still an issue as it is done by community.
Aim This study aims to explore the handler’s knowledge, perception, and practice in handling the remains.
Method This study elaborates qualitative design in exploring the handler’s knowledge, perception, and practice in handling the remains dealing with universal precaution during the handling of the deceased body of COVID-19. The data is obtained through in-depth interview with guides.
Result The majority of participants were acknowledged that the universal precaution is a precautionary conduct which remains general and nontechnical. Technicality on the universal precaution such as personal protective equipment and safety standards for infectious substance on the dead body are still incomprehensive. The perception of each handler of the body is still obscure. It was showed by cautious/apprehensive sense predominated the handlers in handling the dead body.
Conclusion Improving the knowledge and strengthening the network of the handlers among the community play an important role in interrupting the chain of transmission of COVID-19 in the community.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding is available for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Faculty of Medicine, Islamic University of North Sumatra, Indonesia
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available by requested
